Vaccinex News

Slightly above 67% of Vaccinex's investor base is looking to short. The analysis of overall sentiment of trading Vaccinex stock suggests that many investors are alarmed at this time. Vaccinex's investing sentiment can be driven by a variety of factors including economic data, Vaccinex's earnings reports, geopolitical events, and overall market trends.
  
over a month ago at www.macroaxis.com         
Acquisition by Maurice Zauderer of 1877 shares of Vaccinex at 8.21 subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Disposition of 3149 shares by Van Strydonck, Gerald E. of Vaccinex at 0.72 subject to Rule 16b-3
Macroaxis News
over two months ago at gurufocus.com         
Vaccinex Announces Receipt of Delisting Notification from Nasdaq
Gurufocus Stories at Macroaxis
over two months ago at seekingalpha.com         
Vaccinex receives delisting notice from Nasdaq, shares down over 49
seekingalpha News
over two months ago at gurufocus.com         
Vaccinex Faces Nasdaq Delisting Amid Financial Struggles Shares Drop 62
Gurufocus Stories at Macroaxis
over two months ago at benzinga.com         
Vaccinex Faces Nasdaq Delisting Whats Going On With The Stock?
benzinga news
over two months ago at thelincolnianonline.com         
Vaccinex Trading 11.1 percent Higher Whats Next?
news
over two months ago at seekingalpha.com         
Vaccinex reports Q3 figures
seekingalpha News
over two months ago at gurufocus.com         
Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Acquires Shares in Vaccinex Inc
Gurufocus Stories at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Maurice Zauderer of 46153 shares of Vaccinex at 3.25 subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
Vaccinex Provides Update on ActivMAb Platform Multiple Project Deals and Presentation at SITC
Yahoo News
over three months ago at finance.yahoo.com         
Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatm...
Yahoo News
over three months ago at globenewswire.com         
Vaccinex Reports New Findings for SIGNAL-AD Phase 1b2 Trial of Pepinemab at Clinical Trials on Alzhe...
Macroaxis News: globenewswire.com
over three months ago at finance.yahoo.com         
Vaccinex Reports New Findings for SIGNAL-AD Phase 1b2 Trial of Pepinemab at Clinical Trials on Alzhe...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Vaccinex that are available to investors today. That information is available publicly through Vaccinex media outlets and privately through word of mouth or via Vaccinex internal channels. However, regardless of the origin, that massive amount of Vaccinex data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Vaccinex news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vaccinex relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vaccinex's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vaccinex alpha.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Vaccinex Stock

If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges